U.S. Carnival, FedEx, Micron Technology
June 27 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carnival, FedEx and Micron Technology, on Thursday.
HIGHLIGHTS
* Carnival Corp CCL.N: Macquarie raises target price to $25 from $24 |
* FedEx Corp FDX.N: Daiwa Capital Markets raises target price to $318 from $296 |
* Micron Technology Inc MU.O: JP Morgan raises target price to $180 from $130 |
* Unifirst Corp UNF.N: JP Morgan raises target price to $175 from $170 |
* Veeco Instruments Inc VECO.O: Oppenheimer raises target price to $55 from $45 |
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Acadia Pharmaceuticals ACAD.O: BMO initiates coverage with outperform rating; PT $31 |
* AGCO Corp AGCO.N: Jefferies cuts target price to $120 from $135 |
* AIG AIG.N: Evercore ISI cuts target price to $78 from $81 |
* Alnylam Pharmaceuticals Inc ALNY.O: RBC raises target price to $265 from $250 |
* Alnylam Pharmaceuticals Inc ALNY.O: Stifel raises target price to $295 from $215 |
* Amalgamated Financial AMAL.O: JP Morgan raises target price to $32.5 from $31.5 |
* Arista Networks Inc ANET.N: Citigroup raises target price to $385 from $330 |
* Astrana Health Inc ASTH.O: Stifel raises target price to $48 from $45 |
* Bank of New York Mellon Corp BK.N: KBW raises target price to $70 from $60 |
* Bank of New York Mellon Corp BK.N: KBW raises to outperform from market perform |
* Bankunited Inc BKU.N: JP Morgan raises target price to $34.5 from $33 |
* Boston Properties Inc BXP.N: Deutsche Bank cuts target price to $65 from $74 |
* Caci International Inc CACI.N: Truist Securities raises PT to $500 from $450 |
* Cargo Therapeutics CRGX.O: Piper Sandler initiates coverage with overweight rating; PT $37 |
* Carnival Corp CCL.N: BofA Global Research raises price objective to $24 from $23 |
* Carnival Corp CCL.N: Jefferies raises target price to $26 from $25 |
* Carnival Corp CCL.N: Macquarie raises target price to $25 from $24 |
* Carrier Global Corp CARR.N: Oppenheimer raises target price to $71 from $64 |
* Celanese Corp CE.N: Citigroup cuts target price to $148 from $167 |
* Chewy Inc CHWY.N: Wedbush raises target price to $35 from $28 |
* Columbia Banking System Inc COLB.O: JP Morgan cuts target price to $22 from $23 |
* Comerica Inc CMA.N: JP Morgan cuts target price to $57 from $62 |
* Crescent Energy Co CRGY.N: KeyBanc initiates coverage with overweight rating; PT $16 |
* Cullen/Frost Bankers Inc CFR.N: JP Morgan cuts target price to $130 from $140 |
* Datadog Inc DDOG.O: Mizuho raises target price to $135 from $130 |
* Dynatrace Inc DT.N: Piper Sandler initiates coverage with neutral rating; PT $50 |
* Eastman Chemical Co EMN.N: Citigroup cuts target price to $111 from $114 |
* EQT Corp EQT.N: JP Morgan raises target price to $42 from $40 |
* Exact Sciences EXAS.O: BTIG cuts target price to $70 from $80 |
* Exact Sciences EXAS.O: Scotiabank initiates coverage with sector outperform rating |
* Exact Sciences EXAS.O: Scotiabank initiates coverage with target price $70 |
* FB Financial Corp FBK.N: JP Morgan cuts target price to $42 from $43 |
* FedEx Corp FDX.N: Daiwa Capital Markets raises target price to $318 from $296 |
* FedEx Corp FDX.N: Stephens raises target price to $360 from $325 |
* First Hawaiian Inc FHB.O: JP Morgan cuts target price to $24 from $25.5 |
* Five9 Inc FIVN.O: Deutsche Bank cuts target price to $65 from $80 |
* Gcm Grosvenor Inc GCMG.O: TD Cowen raises target price to $12 from $11.5 |
* Genedx Holdings Corp WGS.O: BTIG raises target price to $35 from $19 |
* General Mills GIS.N: Bernstein cuts target price to $69 from $70 |
* General Mills GIS.N: Citigroup cuts target price to $68 from $71 |
* General Mills GIS.N: Deutsche Bank cuts target price to $66 from $70 |
* General Mills GIS.N: Jefferies cuts target price to $66 from $69 |
* General Mills GIS.N: JP Morgan cuts target price to $63 from $70 |
* General Mills GIS.N: Stifel cuts target price to $70 from $77 |
* General Mills GIS.N: TD Cowen cuts target price to $65 from $70 |
* Ginkgo Bioworks Holdings Inc DNA.N: BTIG cuts target price to $0.2 from $0.5 |
* Goldman Sachs GS.N: KBW raises target price to $520 from $485 |
* Goldman Sachs GS.N: Morgan Stanley cuts target price to $475 from $486 |
* Grindr Inc GRND.N: Raymond James raises target price to $15 from $14 |
* Grindr Inc GRND.N: TD Cowen raises target price to $14 from $12 |
* Guidewire Software Inc GWRE.N: RBC raises target price to $170 from $130 |
* HBT Financial Inc HBT.O: JP Morgan cuts target price to $21 from $22 |
* Hims & Hers Health Inc HIMS.N: Jefferies raises target price to $23 from $14 |
* Hologic Inc HOLX.O: Stephens initiates coverage with overweight rating; PT $87 |
* Huntington Bancshares Inc HBAN.O: JP Morgan cuts target price to $16.5 from $17 |
* Huntsman Corp HUN.N: Citigroup cuts target price to $24 from $26 |
* Hut 8 Corp HUT.O: Canaccord Genuity raises target price to $22 from $14 |
* I3 Verticals Inc IIIV.O: Raymond James raises target price to $31 from $30 |
* I3 Verticals Inc IIIV.O: Stephens raises target price to $29 from $27 |
* Ionis Pharmaceuticals Inc IONS.O: Stifel raises target price to $53 from $50 |
* Jasper Therapeutics Inc JSPR.O: Stifel initiates coverage with buy rating; PT $86 |
* Keycorp KEY.N: JP Morgan cuts target price to $16.5 from $17.5 |
* Kyndryl Holdings KD.N: Oppenheimer initiates coverage with Outperform rating; PT $33 |
* Leggett & Platt Inc LEG.N: Truist Securities cuts target price to $11 from $13 |
* Levi Strauss & Co LEVI.N: BofA Global Research raises price objective to $22 from $19 |
* Levi Strauss & Co LEVI.N: JP Morgan cuts target price to $20 from $21 |
* Live Oak Bancshares Inc LOB.N: JP Morgan cuts target price to $45 from $46 |
* Lockheed Martin Corp LMT.N: Bernstein raises target price to $514 from $500 |
* Lyell Immunopharma, Inc. LYEL.O: H.C. Wainwright cuts to neutral from buy |
* Micron Technology Inc MU.O: Goldman Sachs raises target price to $158 from $138 |
* Micron Technology Inc MU.O: JP Morgan raises target price to $180 from $130 |
* Micron Technology Inc MU.O: Needham raises target price to $150 from $120 |
* Micron Technology Inc MU.O: Piper Sandler raises target price to $150 from $130 |
* Micron Technology Inc MU.O: TD Cowen raises target price to $160 from $150 |
* Myriad Genetics Inc MYGN.O: Scotiabank initiates coverage with sector outperform rating |
* Myriad Genetics Inc MYGN.O: Scotiabank initiates coverage with target price $29 |
* Net Power Inc NPWR.N: Citigroup raises target price to $11 from $9 |
* Neurogene Inc NGNE.O: BMO initiates coverage with outperform rating; target price $65 |
* Nextera Energy Inc NEE.N: Citigroup raises target price to $84 from $69 |
* Northern Oil and Gas Inc NOG.N: Piper Sandler raises target price to $45 from $43 |
* Northern Trust Corp NTRS.O: KBW cuts target price to $85 from $92 |
* Nurix Therapeutics Inc NRIX.O: RBC raises target price to $26 from $23 |
* Nvidia Corp NVDA.O: Truist Securities raises target price to $140 from $128.80 |
* Pagerduty Inc PD.N: JP Morgan initiates coverage with neutral rating; PT $24 |
* Pinnacle Financial Partners Inc PNFP.O: JP Morgan cuts target price to $105 from $108 |
* Sabra Health Care REIT Inc SBRA.O: Truist Securities raises PT to $16 from $15 |
* Savara Inc SVRA.O: Guggenheim raises target price to $10 from $8 |
* Savara Inc SVRA.O: H.C. Wainwright raises target price to $10 from $6 |
* Senseonics Holdings Inc SENS.A: Jefferies cuts target price to $0.3 from $0.4 |
* Sentinelone Inc S.N: D.A. Davidson raises target price to $18.5 from $17 |
* Sirius XM Holdings Inc SIRI.O: Guggenheim cuts target price to $2.90 from $3.30 |
* Sphere Entertainment Co SPHR.N: Guggenheim cuts target price to $43 from $48 |
* Sprout Social Inc SPT.O: Baird cuts target price to $38 from $45 |
* State Street Corp STT.N: KBW cuts target price to $84 from $88 |
* Stitch Fix Inc SFIX.O: Canaccord Genuity raises target price to $4.50 from $3.50 |
* Synovus Financial Corp SNV.N: JP Morgan raises target price to $49 from $48 |
* Taysha Gene Therapies TSHA.O: BMO initiates coverage with outperform rating; PT $5 |
* Tigo Energy Inc TYGO.O: UBS raises target price to $25 from $18 |
* Transdigm Group Inc TDG.N: Vertical Research ups target price to $1,520 from $1,400 |
* Unifirst Corp UNF.N: JP Morgan raises target price to $175 from $170 |
* Unifirst Corp UNF.N: UBS raises target price to $190 from $186 |
* Unity Software Inc U.N: Macquarie cuts target price to $14 from $20 |
* US Bancorp USB.N: JP Morgan cuts to neutral from overweight |
* Valley National Bancorp VLY.O: JP Morgan cuts target price to $8 from $8.5 |
* Veeco Instruments Inc VECO.O: Oppenheimer raises target price to $55 from $45 |
* Verizon VZ.N: RBC raises target price to $42 from $40 |
* Webster Financial Corp WBS.N: JP Morgan cuts target price to $58 from $63 |
* Workiva Inc WK.N: Baird cuts target price to $94 from $105 |
* Worthington Enterprises Inc WOR.N: Canaccord Genuity cuts PT to $52 from $64 |
(Compiled by Bengaluru Newsroom)
</body></html>Gerelateerde activa
Laatste nieuws
Disclaimer: De entiteiten van de XM Group bieden diensten en toegang tot ons online handelsplatform op basis van uitsluitend-uitvoering, waardoor een persoon de beschikbare content op of via de website kan bekijken en/of gebruiken, zonder dat dit is bedoeld voor wijziging of uitbreiding. Dergelijk(e) toegang en gebruik vallen onder: (i) de algemene voorwaarden; (ii) risicowaarschuwingen; en de (iii) volledige disclaimer. Dergelijke content wordt daarom alleen aangeboden als algemene informatie. Wees u er daarnaast vooral van bewust dat de inhoud op ons online handelsplatform geen verzoek of aanbieding omvat om transacties op de financiële markten uit te voeren. Het beleggen op welke financiële markt dan ook vormt een aanzienlijk risico voor uw vermogen.
Alle materialen die op ons online handelsplatform worden gepubliceerd zijn bedoeld voor educatieve/informatieve doeleinden en omvatten geen – en moeten niet worden beschouwd als het bevatten van – financieel, vermogensbelastings- of handelsadvies en aanbevelingen, of een overzicht van onze handelsprijzen, of een aanbod of aanvraag van een transactie in financiële instrumenten of ongevraagde financiële promoties voor u.
Alle content van derden, alsmede content die is voorbereid door XM, zoals opinies, nieuws, onderzoeken, analyses, prijzen en andere informatie of koppelingen naar externe websites op deze website worden aangeboden op een 'zoals-ze-zijn'-basis, als algemene marktcommentaren, en vormen geen beleggingsadvies. Voor zover dat content wordt beschouwd als beleggingsonderzoek, moet u zich ervan bewust zijn en accepteren dat de content niet bedoeld was en niet is voorbereid in overeenstemming met de wettelijke vereisten die zijn opgesteld om de onafhankelijkheid van beleggingsonderzoek te bevorderen en als zodanig onder de geldende wetgeving en richtlijnen moet worden beschouwd als marketingcommunicatie. Zorg ervoor dat u onze Mededeling over niet-onafhankelijk beleggingsonderzoek en risicowaarschuwing in verband met de voorgaande informatie doorneemt en begrijpt; die kunt u hier lezen.
